25 XP   0   0   10

Myriad Genetics Inc
Buy, Hold or Sell?

Let's analyse Myriad together

PenkeI guess you are interested in Myriad Genetics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Myriad Genetics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Myriad Genetics Inc

I send you an email if I find something interesting about Myriad Genetics Inc.

Quick analysis of Myriad (30 sec.)










What can you expect buying and holding a share of Myriad? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$8.71
Expected worth in 1 year
$7.57
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$-1.14
Return On Investment
-6.2%

For what price can you sell your share?

Current Price per Share
$18.60
Expected price per share
$13.82 - $20.59
How sure are you?
50%

1. Valuation of Myriad (5 min.)




Live pricePrice per Share (EOD)

$18.60

Intrinsic Value Per Share

$-34.12 - $-18.84

Total Value Per Share

$-25.41 - $-10.13

2. Growth of Myriad (5 min.)




Is Myriad growing?

Current yearPrevious yearGrowGrow %
How rich?$783.2m$924.9m-$165.7m-21.8%

How much money is Myriad making?

Current yearPrevious yearGrowGrow %
Making money-$65.8m-$28m-$37.8m-57.5%
Net Profit Margin-35.3%-16.6%--

How much money comes from the company's main activities?

3. Financial Health of Myriad (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#37 / 145

Most Revenue
#49 / 145

Most Profit
#136 / 145

What can you expect buying and holding a share of Myriad? (5 min.)

Welcome investor! Myriad's management wants to use your money to grow the business. In return you get a share of Myriad.

What can you expect buying and holding a share of Myriad?

First you should know what it really means to hold a share of Myriad. And how you can make/lose money.

Speculation

The Price per Share of Myriad is $18.60. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Myriad.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Myriad, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $8.71. Based on the TTM, the Book Value Change Per Share is $-0.29 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.23 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Myriad.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.35-1.9%-0.73-3.9%-0.31-1.7%-0.37-2.0%-0.06-0.3%
Usd Book Value Change Per Share1.116.0%-0.29-1.5%-0.23-1.2%-0.16-0.8%0.030.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.020.1%0.020.1%
Usd Total Gains Per Share1.116.0%-0.29-1.5%-0.23-1.2%-0.13-0.7%0.050.3%
Usd Price Per Share19.14-20.40-19.24-22.74-27.83-
Price to Earnings Ratio-13.79--8.42--19.12--25.40--34.16-
Price-to-Total Gains Ratio17.27--18.16--207.70--209.63--307.78-
Price to Book Ratio2.20-2.41-1.86-2.21-2.99-
Price-to-Total Gains Ratio17.27--18.16--207.70--209.63--307.78-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share18.6
Number of shares53
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.02
Usd Book Value Change Per Share-0.29-0.16
Usd Total Gains Per Share-0.29-0.13
Gains per Quarter (53 shares)-15.16-7.07
Gains per Year (53 shares)-60.63-28.28
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-61-715-33-38
20-121-13210-66-66
30-182-19315-99-94
40-243-25419-133-122
50-303-31524-166-150
60-364-37629-199-178
70-424-43734-232-206
80-485-49839-265-234
90-546-55944-298-262
100-606-62049-332-290

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%20.020.00.050.0%44.068.00.039.3%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%6.014.00.030.0%16.024.00.040.0%48.064.00.042.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%1.00.019.05.0%2.00.038.05.0%2.00.0110.01.8%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%6.014.00.030.0%16.024.00.040.0%48.064.00.042.9%

Fundamentals of Myriad

About Myriad Genetics Inc

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and pharmacogenomics. It also provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing test to help determine the therapy for patients with metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic Test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. The company also offers Prolaris Prostate Cancer Prognostic Test, an RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic Test, an RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor, a solution for precision oncology; and Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus. It provides Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; SneakPeek, a non-invasive blood test that predicts the gender of a fetus; and GeneSight Psychotropic Mental Health Medication Test, a DNA genotyping test to aid psychotropic drug selection for patients suffering from depression, anxiety, attention-deficit, hyperactivity disorder, and other mental health conditions. It has a strategic collaboration with Illumina, Inc., Memorial Sloan Kettering Cancer Center, the University of Texas MD Anderson Cancer Center, SimonMed, and Onsite Women's Health. Myriad Genetics, Inc. was incorporated in 1992 and is headquartered in Salt Lake City, Utah.

Fundamental data was last updated by Penke on 2024-04-11 15:25:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Myriad Genetics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Myriad earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Myriad to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -15.9% means that $-0.16 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Myriad Genetics Inc:

  • The MRQ is -15.9%. The company is making a huge loss. -2
  • The TTM is -35.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-15.9%TTM-35.3%+19.4%
TTM-35.3%YOY-16.6%-18.7%
TTM-35.3%5Y-20.3%-15.0%
5Y-20.3%10Y-4.5%-15.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.9%-7.7%-8.2%
TTM-35.3%-6.7%-28.6%
YOY-16.6%2.4%-19.0%
5Y-20.3%-1.5%-18.8%
10Y-4.5%-3.4%-1.1%
1.1.2. Return on Assets

Shows how efficient Myriad is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Myriad to the Diagnostics & Research industry mean.
  • -2.7% Return on Assets means that Myriad generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Myriad Genetics Inc:

  • The MRQ is -2.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.7%TTM-5.6%+2.9%
TTM-5.6%YOY-2.3%-3.3%
TTM-5.6%5Y-2.6%-3.1%
5Y-2.6%10Y-0.2%-2.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.7%-1.7%-1.0%
TTM-5.6%-1.3%-4.3%
YOY-2.3%-0.9%-1.4%
5Y-2.6%-0.5%-2.1%
10Y-0.2%-0.9%+0.7%
1.1.3. Return on Equity

Shows how efficient Myriad is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Myriad to the Diagnostics & Research industry mean.
  • -4.0% Return on Equity means Myriad generated $-0.04 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Myriad Genetics Inc:

  • The MRQ is -4.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.0%TTM-8.8%+4.8%
TTM-8.8%YOY-3.1%-5.8%
TTM-8.8%5Y-3.9%-4.9%
5Y-3.9%10Y-0.6%-3.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.0%-0.7%-3.3%
TTM-8.8%-0.1%-8.7%
YOY-3.1%0.3%-3.4%
5Y-3.9%-1.4%-2.5%
10Y-0.6%-2.3%+1.7%

1.2. Operating Efficiency of Myriad Genetics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Myriad is operating .

  • Measures how much profit Myriad makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Myriad to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Myriad Genetics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-30.8%+30.8%
TTM-30.8%YOY-18.4%-12.4%
TTM-30.8%5Y-20.0%-10.8%
5Y-20.0%10Y-3.5%-16.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--6.2%+6.2%
TTM-30.8%0.5%-31.3%
YOY-18.4%4.3%-22.7%
5Y-20.0%3.7%-23.7%
10Y-3.5%-1.3%-2.2%
1.2.2. Operating Ratio

Measures how efficient Myriad is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.90 means that the operating costs are $0.90 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Myriad Genetics Inc:

  • The MRQ is 0.899. The company is less efficient in keeping operating costs low.
  • The TTM is 1.280. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.899TTM1.280-0.381
TTM1.280YOY1.184+0.096
TTM1.2805Y1.232+0.048
5Y1.23210Y1.045+0.187
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8991.296-0.397
TTM1.2801.301-0.021
YOY1.1841.238-0.054
5Y1.2321.268-0.036
10Y1.0451.217-0.172

1.3. Liquidity of Myriad Genetics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Myriad is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 2.01 means the company has $2.01 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Myriad Genetics Inc:

  • The MRQ is 2.012. The company is able to pay all its short-term debts. +1
  • The TTM is 1.609. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.012TTM1.609+0.402
TTM1.609YOY2.593-0.984
TTM1.6095Y2.453-0.844
5Y2.45310Y3.153-0.700
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0122.111-0.099
TTM1.6092.298-0.689
YOY2.5932.581+0.012
5Y2.4533.012-0.559
10Y3.1533.081+0.072
1.3.2. Quick Ratio

Measures if Myriad is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Myriad to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.79 means the company can pay off $0.79 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Myriad Genetics Inc:

  • The MRQ is 0.790. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.124. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ0.790TTM1.124-0.335
TTM1.124YOY2.811-1.687
TTM1.1245Y2.256-1.131
5Y2.25610Y3.223-0.967
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7901.204-0.414
TTM1.1241.285-0.161
YOY2.8111.565+1.246
5Y2.2561.925+0.331
10Y3.2232.128+1.095

1.4. Solvency of Myriad Genetics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Myriad assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Myriad to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.32 means that Myriad assets are financed with 31.7% credit (debt) and the remaining percentage (100% - 31.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Myriad Genetics Inc:

  • The MRQ is 0.317. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.347. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.317TTM0.347-0.030
TTM0.347YOY0.241+0.106
TTM0.3475Y0.313+0.034
5Y0.31310Y0.267+0.045
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3170.421-0.104
TTM0.3470.407-0.060
YOY0.2410.394-0.153
5Y0.3130.448-0.135
10Y0.2670.446-0.179
1.4.2. Debt to Equity Ratio

Measures if Myriad is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Myriad to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 46.4% means that company has $0.46 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Myriad Genetics Inc:

  • The MRQ is 0.464. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.540. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.464TTM0.540-0.076
TTM0.540YOY0.319+0.221
TTM0.5405Y0.463+0.077
5Y0.46310Y0.390+0.073
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4640.606-0.142
TTM0.5400.567-0.027
YOY0.3190.631-0.312
5Y0.4630.658-0.195
10Y0.3900.742-0.352

2. Market Valuation of Myriad Genetics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Myriad generates.

  • Above 15 is considered overpriced but always compare Myriad to the Diagnostics & Research industry mean.
  • A PE ratio of -13.79 means the investor is paying $-13.79 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Myriad Genetics Inc:

  • The EOD is -13.399. Based on the earnings, the company is expensive. -2
  • The MRQ is -13.788. Based on the earnings, the company is expensive. -2
  • The TTM is -8.424. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-13.399MRQ-13.788+0.389
MRQ-13.788TTM-8.424-5.364
TTM-8.424YOY-19.124+10.700
TTM-8.4245Y-25.398+16.975
5Y-25.39810Y-34.161+8.762
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-13.399-0.261-13.138
MRQ-13.788-0.409-13.379
TTM-8.424-0.341-8.083
YOY-19.1240.002-19.126
5Y-25.3984.832-30.230
10Y-34.1615.198-39.359
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Myriad Genetics Inc:

  • The EOD is -6.130. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.308. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.763. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.130MRQ-6.308+0.178
MRQ-6.308TTM-12.763+6.455
TTM-12.763YOY-13.623+0.860
TTM-12.7635Y-3.346-9.417
5Y-3.34610Y6.743-10.089
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-6.130-0.291-5.839
MRQ-6.308-0.441-5.867
TTM-12.763-1.388-11.375
YOY-13.623-2.079-11.544
5Y-3.346-1.446-1.900
10Y6.743-1.971+8.714
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Myriad is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 2.20 means the investor is paying $2.20 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Myriad Genetics Inc:

  • The EOD is 2.135. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.197. Based on the equity, the company is underpriced. +1
  • The TTM is 2.410. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.135MRQ2.197-0.062
MRQ2.197TTM2.410-0.213
TTM2.410YOY1.863+0.547
TTM2.4105Y2.214+0.196
5Y2.21410Y2.987-0.773
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD2.1351.857+0.278
MRQ2.1972.228-0.031
TTM2.4102.222+0.188
YOY1.8633.104-1.241
5Y2.2143.447-1.233
10Y2.9874.036-1.049
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Myriad Genetics Inc.

3.1. Institutions holding Myriad Genetics Inc

Institutions are holding 103.048% of the shares of Myriad Genetics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc16.30970.00721465834910314247.569
2023-12-31Vanguard Group Inc11.07570.004299542337894968.6145
2023-12-31Camber Capital Management LLC8.49513.72427635000100000015.0716
2023-12-31Wellington Management Company LLP8.03310.02587219706122344620.4035
2023-12-31Glenview Capital Management LLC5.87932.16265283982150000039.6408
2023-12-31State Street Corporation5.23020.00444700631177510.3791
2023-12-31Earnest Partners LLC4.35480.3741391391344063212.6863
2023-12-31Millennium Management LLC3.85130.02873461337-19866-0.5707
2023-12-31Bank of America Corp3.32230.00582985897-11900-0.397
2023-12-31Dimensional Fund Advisors, Inc.2.98290.0152680918893303.4469
2023-12-31Artisan Partners Limited Partnership2.70750.07172433377-103770-4.09
2023-09-30D. E. Shaw & Co LP2.42330.036521779251509037.4446
2023-12-31Goldman Sachs Group Inc2.42110.0037217597898495782.6985
2023-12-31SEI Investments Co2.40490.0664216143463814741.8928
2023-12-31Disciplined Growth Investors Inc2.17550.81711955236-18076-0.916
2023-12-31Geode Capital Management, LLC2.08270.003818718571449738.3951
2023-12-31Pictet Asset Manangement SA1.44060.02731294774765286.2818
2023-12-31Nuveen Asset Management, LLC1.16820.00651049945604590135.7546
2023-12-31Northern Trust Corp1.04830.0033942137-80002-7.8269
2023-12-31Charles Schwab Investment Management Inc1.03050.0045926159413534.6737
Total 88.4377.392879482788+8499916+10.7%

3.2. Funds holding Myriad Genetics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-28iShares Core S&P Small-Cap ETF6.65350.15875979815-21552-0.3591
2023-12-31Vanguard Explorer Inv3.83950.30893450725509201.4977
2024-02-29Vanguard Total Stock Mkt Idx Inv2.93950.00362641911-9785-0.369
2024-03-31EARNEST Partners Smid Cap Core Founders2.44041.24121933491000844.7812
2024-02-29Vanguard Small Cap Index2.43860.03262191712203110.9354
2024-03-28iShares Russell 2000 ETF2.38690.0698214520210350.0483
2024-03-28SPDR® S&P Biotech ETF2.31020.58622076263262001.278
2023-12-31Artisan International Small-Mid Investor1.70210.6531529799-38928-2.4815
2023-12-31Artisan Non-U.S. Small-Mid Growth Comp1.70210.65231529799-38928-2.4815
2024-02-29Vanguard Small Cap Value Index Inv1.66610.05891497414131330.8848
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.48050.02731330573-5428-0.4063
2024-03-28iShares Russell 2000 Value ETF0.9170.1401824155-523-0.0634
2024-01-31Fidelity Small Cap Index0.90870.0705816657126821.5774
2024-03-28SPDR® Portfolio S&P 600 Sm Cap ETF0.87150.15887832588050.1029
2024-02-29Vanguard Tax-Managed Small Cap Adm0.77080.163269273100
2024-03-28iShares Biotechnology ETF0.72140.181264838300
2023-10-13Pictet Biopharmaceutical Mother0.67260.606360450016766538.3818
2023-12-31EARNEST Partners ML SMID Core Wrap0.62771.154256411556163722664.9314
2024-03-28iShares S&P Small-Cap 600 Value ETF0.61890.1642556205-5460-0.9721
2024-01-31CREF Stock R10.57920.009452053600
Total 36.24726.440232577102+833868+2.6%

3.3. Insider Transactions

Insiders are holding 2.013% of the shares of Myriad Genetics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-01Richard Bryan RiggsbeeSELL3000015.69
2023-06-02Daniel K SpiegelmanSELL863823.01

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Myriad Genetics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.108-0.286+126%-0.228+121%-0.156+114%0.030+3622%
Book Value Per Share--8.7128.447+3%10.292-15%10.263-15%9.586-9%
Current Ratio--2.0121.609+25%2.593-22%2.453-18%3.153-36%
Debt To Asset Ratio--0.3170.347-9%0.241+31%0.313+1%0.267+18%
Debt To Equity Ratio--0.4640.540-14%0.319+46%0.463+0%0.390+19%
Dividend Per Share----0%-0%0.023-100%0.019-100%
Eps---0.347-0.732+111%-0.312-10%-0.366+6%-0.063-82%
Free Cash Flow Per Share---0.759-0.512-32%-0.422-44%-0.185-76%0.067-1235%
Free Cash Flow To Equity Per Share--0.597-0.087+115%-0.444+174%-0.216+136%0.027+2105%
Gross Profit Margin--1.0001.0000%1.0000%1.014-1%1.007-1%
Intrinsic Value_10Y_max---18.840--------
Intrinsic Value_10Y_min---34.123--------
Intrinsic Value_1Y_max---0.045--------
Intrinsic Value_1Y_min---1.624--------
Intrinsic Value_3Y_max---1.539--------
Intrinsic Value_3Y_min---6.464--------
Intrinsic Value_5Y_max---4.727--------
Intrinsic Value_5Y_min---13.003--------
Market Cap1671673065.600-3%1720686000.0001833343313.800-6%1729192999.0400%2043666815.948-16%2501634804.976-31%
Net Profit Margin---0.159-0.353+123%-0.166+5%-0.203+28%-0.045-72%
Operating Margin----0.3080%-0.1840%-0.2000%-0.0350%
Operating Ratio--0.8991.280-30%1.184-24%1.232-27%1.045-14%
Pb Ratio2.135-3%2.1972.410-9%1.863+18%2.214-1%2.987-26%
Pe Ratio-13.399+3%-13.788-8.424-39%-19.124+39%-25.398+84%-34.161+148%
Price Per Share18.600-3%19.14020.398-6%19.240-1%22.739-16%27.835-31%
Price To Free Cash Flow Ratio-6.130+3%-6.308-12.763+102%-13.623+116%-3.346-47%6.743-194%
Price To Total Gains Ratio16.787-3%17.274-18.162+205%-207.700+1302%-209.633+1314%-307.784+1882%
Quick Ratio--0.7901.124-30%2.811-72%2.256-65%3.223-75%
Return On Assets---0.027-0.056+107%-0.023-15%-0.026-5%-0.002-94%
Return On Equity---0.040-0.088+121%-0.031-23%-0.039-2%-0.006-86%
Total Gains Per Share--1.108-0.286+126%-0.228+121%-0.133+112%0.048+2190%
Usd Book Value--783200000.000759250000.000+3%924975000.000-15%922390000.000-15%861518225.000-9%
Usd Book Value Change Per Share--1.108-0.286+126%-0.228+121%-0.156+114%0.030+3622%
Usd Book Value Per Share--8.7128.447+3%10.292-15%10.263-15%9.586-9%
Usd Dividend Per Share----0%-0%0.023-100%0.019-100%
Usd Eps---0.347-0.732+111%-0.312-10%-0.366+6%-0.063-82%
Usd Free Cash Flow---68200000.000-46050000.000-32%-37900000.000-44%-16635000.000-76%6007725.000-1235%
Usd Free Cash Flow Per Share---0.759-0.512-32%-0.422-44%-0.185-76%0.067-1235%
Usd Free Cash Flow To Equity Per Share--0.597-0.087+115%-0.444+174%-0.216+136%0.027+2105%
Usd Market Cap1671673065.600-3%1720686000.0001833343313.800-6%1729192999.0400%2043666815.948-16%2501634804.976-31%
Usd Price Per Share18.600-3%19.14020.398-6%19.240-1%22.739-16%27.835-31%
Usd Profit---31200000.000-65825000.000+111%-28000000.000-10%-32935000.000+6%-5845325.000-81%
Usd Revenue--196600000.000188300000.000+4%169600000.000+16%174630000.000+13%182757600.000+8%
Usd Total Gains Per Share--1.108-0.286+126%-0.228+121%-0.133+112%0.048+2190%
 EOD+2 -6MRQTTM+24 -8YOY+11 -215Y+16 -1910Y+12 -23

4.2. Fundamental Score

Let's check the fundamental score of Myriad Genetics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-13.399
Price to Book Ratio (EOD)Between0-12.135
Net Profit Margin (MRQ)Greater than0-0.159
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.790
Current Ratio (MRQ)Greater than12.012
Debt to Asset Ratio (MRQ)Less than10.317
Debt to Equity Ratio (MRQ)Less than10.464
Return on Equity (MRQ)Greater than0.15-0.040
Return on Assets (MRQ)Greater than0.05-0.027
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Myriad Genetics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.907
Ma 20Greater thanMa 5019.940
Ma 50Greater thanMa 10021.390
Ma 100Greater thanMa 20020.781
OpenGreater thanClose18.510
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Operating Income  -46,000-6,200-52,200-61,500-113,70053,600-60,100141,50081,400



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,146,500
Total Liabilities363,300
Total Stockholder Equity783,200
 As reported
Total Liabilities 363,300
Total Stockholder Equity+ 783,200
Total Assets = 1,146,500

Assets

Total Assets1,146,500
Total Current Assets313,600
Long-term Assets832,900
Total Current Assets
Cash And Cash Equivalents 132,100
Short-term Investments 8,800
Net Receivables 114,300
Inventory 22,000
Other Current Assets 19,400
Total Current Assets  (as reported)313,600
Total Current Assets  (calculated)296,600
+/- 17,000
Long-term Assets
Property Plant Equipment 180,600
Goodwill 287,400
Intangible Assets 349,500
Long-term Assets Other 15,400
Long-term Assets  (as reported)832,900
Long-term Assets  (calculated)832,900
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities155,900
Long-term Liabilities207,400
Total Stockholder Equity783,200
Total Current Liabilities
Accounts payable 25,800
Other Current Liabilities 10,400
Total Current Liabilities  (as reported)155,900
Total Current Liabilities  (calculated)36,200
+/- 119,700
Long-term Liabilities
Long term Debt 38,500
Capital Lease Obligations Min Short Term Debt113,600
Long-term Liabilities Other 41,300
Long-term Liabilities  (as reported)207,400
Long-term Liabilities  (calculated)193,400
+/- 14,000
Total Stockholder Equity
Total Stockholder Equity (as reported)783,200
Total Stockholder Equity (calculated)0
+/- 783,200
Other
Capital Stock900
Common Stock Shares Outstanding 89,900
Net Invested Capital 821,700
Net Working Capital 157,700
Property Plant and Equipment Gross 300,500



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-30
> Total Assets 
0
78,700
81,100
79,600
77,600
73,900
70,200
76,100
74,600
72,600
69,500
67,400
62,800
59,100
56,200
53,600
65,100
73,900
77,868
106,375
122,228
161,482
162,245
172,145
161,244
158,924
153,670
157,390
140,102
197,110
182,917
182,823
165,976
156,995
148,329
188,356
177,478
171,362
160,580
158,958
150,035
285,229
278,293
276,603
262,816
262,322
362,149
372,067
373,370
384,358
390,957
499,342
531,228
573,567
620,430
466,421
494,129
540,037
589,563
593,847
610,842
593,609
557,280
610,827
619,735
661,258
699,253
690,635
703,061
717,746
729,028
803,821
781,658
756,681
816,426
823,814
809,006
781,854
779,049
766,200
787,000
871,700
868,200
880,500
1,270,900
1,276,100
1,267,800
1,224,400
1,228,300
1,228,500
1,218,500
1,174,100
1,573,600
1,556,600
1,557,300
1,562,700
1,591,200
1,578,300
1,446,700
1,404,600
1,444,500
1,418,800
1,336,900
1,360,300
1,335,900
1,320,700
1,255,400
1,210,200
1,212,000
1,198,700
1,169,300
1,187,200
1,149,100
1,146,500
1,146,5001,149,1001,187,2001,169,3001,198,7001,212,0001,210,2001,255,4001,320,7001,335,9001,360,3001,336,9001,418,8001,444,5001,404,6001,446,7001,578,3001,591,2001,562,7001,557,3001,556,6001,573,6001,174,1001,218,5001,228,5001,228,3001,224,4001,267,8001,276,1001,270,900880,500868,200871,700787,000766,200779,049781,854809,006823,814816,426756,681781,658803,821729,028717,746703,061690,635699,253661,258619,735610,827557,280593,609610,842593,847589,563540,037494,129466,421620,430573,567531,228499,342390,957384,358373,370372,067362,149262,322262,816276,603278,293285,229150,035158,958160,580171,362177,478188,356148,329156,995165,976182,823182,917197,110140,102157,390153,670158,924161,244172,145162,245161,482122,228106,37577,86873,90065,10053,60056,20059,10062,80067,40069,50072,60074,60076,10070,20073,90077,60079,60081,10078,7000
   > Total Current Assets 
0
67,200
51,900
50,600
52,200
40,400
37,400
48,600
51,600
44,700
31,400
31,700
17,600
23,600
13,500
13,700
31,700
47,400
57,631
85,932
90,367
122,842
133,471
137,199
105,627
99,857
91,929
85,354
72,374
133,660
121,229
102,823
98,122
91,122
93,520
137,193
115,379
109,229
100,771
135,555
127,361
261,809
254,019
252,287
237,804
234,369
334,726
343,262
232,899
229,502
252,948
377,303
365,554
376,921
456,574
366,153
410,351
400,848
563,155
473,976
491,847
538,394
501,446
418,261
460,192
502,280
542,329
530,612
543,881
557,615
566,313
634,733
608,473
580,619
397,190
400,102
376,210
349,575
310,164
283,600
307,300
375,500
372,400
314,500
322,900
341,600
348,300
317,100
325,600
327,000
331,500
326,400
341,900
336,800
342,900
348,600
329,500
365,300
355,200
331,700
394,500
389,400
329,200
538,900
498,900
484,800
427,400
367,100
352,300
274,600
261,600
294,300
265,400
313,600
313,600265,400294,300261,600274,600352,300367,100427,400484,800498,900538,900329,200389,400394,500331,700355,200365,300329,500348,600342,900336,800341,900326,400331,500327,000325,600317,100348,300341,600322,900314,500372,400375,500307,300283,600310,164349,575376,210400,102397,190580,619608,473634,733566,313557,615543,881530,612542,329502,280460,192418,261501,446538,394491,847473,976563,155400,848410,351366,153456,574376,921365,554377,303252,948229,502232,899343,262334,726234,369237,804252,287254,019261,809127,361135,555100,771109,229115,379137,19393,52091,12298,122102,823121,229133,66072,37485,35491,92999,857105,627137,199133,471122,84290,36785,93257,63147,40031,70013,70013,50023,60017,60031,70031,40044,70051,60048,60037,40040,40052,20050,60051,90067,2000
       Cash And Cash Equivalents 
0
28,600
26,300
13,200
14,800
15,300
16,700
15,700
20,400
17,000
13,400
14,600
9,200
17,300
8,300
5,400
15,700
27,700
28,780
56,215
58,632
92,428
96,201
35,937
47,358
53,207
58,568
61,067
48,519
97,027
80,421
61,603
48,233
42,464
46,912
83,983
65,494
62,516
48,393
49,509
38,728
118,582
106,407
98,573
88,625
85,868
194,871
143,432
107,216
114,575
142,392
237,734
230,233
178,985
200,685
63,510
91,196
60,431
102,149
92,840
123,305
67,669
67,378
52,681
62,676
108,848
104,852
86,352
95,583
68,423
112,323
104,073
84,987
71,599
85,798
64,821
69,803
59,709
55,209
64,100
87,400
134,700
120,500
68,500
86,900
108,100
123,800
102,400
87,900
88,700
97,400
110,900
93,300
90,600
84,900
93,200
89,900
81,200
121,000
163,700
118,300
117,000
148,900
118,400
295,200
258,400
165,200
105,200
110,700
56,900
53,600
102,800
76,000
132,100
132,10076,000102,80053,60056,900110,700105,200165,200258,400295,200118,400148,900117,000118,300163,700121,00081,20089,90093,20084,90090,60093,300110,90097,40088,70087,900102,400123,800108,10086,90068,500120,500134,70087,40064,10055,20959,70969,80364,82185,79871,59984,987104,073112,32368,42395,58386,352104,852108,84862,67652,68167,37867,669123,30592,840102,14960,43191,19663,510200,685178,985230,233237,734142,392114,575107,216143,432194,87185,86888,62598,573106,407118,58238,72849,50948,39362,51665,49483,98346,91242,46448,23361,60380,42197,02748,51961,06758,56853,20747,35835,93796,20192,42858,63256,21528,78027,70015,7005,4008,30017,3009,20014,60013,40017,00020,40015,70016,70015,30014,80013,20026,30028,6000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,500
8,700
16,900
23,772
24,287
26,600
24,741
31,851
91,282
49,171
37,173
21,229
12,008
10,011
13,404
12,833
11,172
21,473
21,257
22,499
31,383
26,002
23,441
29,701
64,334
64,269
116,497
122,927
129,171
123,490
117,643
109,476
164,880
81,348
66,576
61,802
90,994
78,107
153,009
201,400
253,345
266,433
284,978
296,500
310,388
305,033
323,630
293,846
293,776
286,845
241,782
232,512
254,180
253,582
290,210
223,834
268,243
272,031
281,996
126,360
121,641
89,807
105,406
79,224
80,700
68,000
84,600
96,200
90,500
61,500
54,400
48,300
48,300
60,400
54,800
59,900
69,700
74,200
74,800
64,800
43,700
52,700
60,400
60,500
54,100
42,100
33,700
27,200
46,000
70,900
81,400
103,200
99,900
82,500
58,000
25,100
18,800
10,300
8,800
8,80010,30018,80025,10058,00082,50099,900103,20081,40070,90046,00027,20033,70042,10054,10060,50060,40052,70043,70064,80074,80074,20069,70059,90054,80060,40048,30048,30054,40061,50090,50096,20084,60068,00080,70079,224105,40689,807121,641126,360281,996272,031268,243223,834290,210253,582254,180232,512241,782286,845293,776293,846323,630305,033310,388296,500284,978266,433253,345201,400153,00978,10790,99461,80266,57681,348164,880109,476117,643123,490129,171122,927116,49764,26964,33429,70123,44126,00231,38322,49921,25721,47311,17212,83313,40410,01112,00821,22937,17349,17191,28231,85124,74126,60024,28723,77216,9008,7004,500000000000000000
       Net Receivables 
0
100
100
0
0
100
400
500
500
700
1,000
600
800
100
1,300
3,200
6,900
1,900
2,247
2,751
3,263
3,766
3,783
5,760
5,435
5,943
7,881
7,453
9,866
16,055
22,071
22,308
20,777
18,869
15,748
14,548
18,079
18,036
17,289
18,381
19,725
19,993
21,588
22,217
23,908
26,926
27,591
32,451
36,047
41,068
41,722
45,432
54,112
42,178
51,678
45,305
44,811
49,508
49,063
47,801
44,216
40,399
47,720
50,847
45,473
44,071
52,449
63,101
64,473
76,552
95,359
97,706
88,032
87,600
98,264
98,676
105,659
86,553
95,187
87,700
85,000
89,400
94,000
95,000
102,800
111,500
119,200
111,300
120,100
127,100
127,000
102,100
123,400
122,500
147,000
138,600
121,800
121,800
105,000
71,000
87,100
91,500
96,500
94,800
93,600
91,300
101,700
109,800
102,200
101,600
119,100
111,700
115,200
114,300
114,300115,200111,700119,100101,600102,200109,800101,70091,30093,60094,80096,50091,50087,10071,000105,000121,800121,800138,600147,000122,500123,400102,100127,000127,100120,100111,300119,200111,500102,80095,00094,00089,40085,00087,70095,18786,553105,65998,67698,26487,60088,03297,70695,35976,55264,47363,10152,44944,07145,47350,84747,72040,39944,21647,80149,06349,50844,81145,30551,67842,17854,11245,43241,72241,06836,04732,45127,59126,92623,90822,21721,58819,99319,72518,38117,28918,03618,07914,54815,74818,86920,77722,30822,07116,0559,8667,4537,8815,9435,4355,7603,7833,7663,2632,7512,2471,9006,9003,2001,3001008006001,000700500500400100001001000
       Other Current Assets 
0
38,500
25,500
37,400
37,400
25,000
20,300
32,400
30,700
27,000
17,000
16,500
7,600
6,200
3,900
600
400
900
2,832
2,679
1,872
1,907
1,635
4,219
3,663
3,534
4,251
4,827
3,978
7,174
5,904
7,740
7,639
8,532
8,361
7,279
5,804
5,236
5,388
3,331
4,639
6,737
3,097
2,326
1,781
3,932
2,788
2,499
8,288
7,283
7,032
3,143
3,102
2,749
2,811
3,993
7,911
5,931
511,183
333
19,293
494,405
451,491
15,289
401,703
428,259
466,710
7,285
10,894
11,681
9,053
8,963
13,625
13,311
21,196
26,975
64,020
48,247
23,445
26,000
32,600
37,700
36,400
22,200
17,800
16,300
9,600
12,900
18,300
18,200
13,800
9,400
15,100
15,600
14,300
41,700
37,000
73,800
37,900
13,800
120,400
120,100
32,000
262,000
20,600
20,000
41,700
36,800
37,300
20,400
24,400
20,800
21,300
19,400
19,40021,30020,80024,40020,40037,30036,80041,70020,00020,600262,00032,000120,100120,40013,80037,90073,80037,00041,70014,30015,60015,1009,40013,80018,20018,30012,9009,60016,30017,80022,20036,40037,70032,60026,00023,44548,24764,02026,97521,19613,31113,6258,9639,05311,68110,8947,285466,710428,259401,70315,289451,491494,40519,293333511,1835,9317,9113,9932,8112,7493,1023,1437,0327,2838,2882,4992,7883,9321,7812,3263,0976,7374,6393,3315,3885,2365,8047,2798,3618,5327,6397,7405,9047,1743,9784,8274,2513,5343,6634,2191,6351,9071,8722,6792,8329004006003,9006,2007,60016,50017,00027,00030,70032,40020,30025,00037,40037,40025,50038,5000
   > Long-term Assets 
0
11,500
29,200
29,000
25,400
33,500
32,800
27,500
23,000
27,900
38,100
35,700
45,200
35,500
42,700
39,900
33,400
26,500
20,237
20,444
31,861
38,640
28,774
34,947
55,617
59,067
61,741
72,036
67,728
63,450
61,688
80,000
67,854
65,873
54,809
51,163
62,099
62,133
59,809
23,403
22,674
23,420
24,274
24,316
25,012
27,953
27,423
28,805
140,471
154,856
138,009
122,039
165,674
196,646
163,856
100,268
83,778
139,189
26,408
119,871
118,995
55,215
55,834
192,566
159,543
158,978
156,924
160,023
159,180
160,131
162,715
169,088
173,185
176,062
419,236
423,712
432,796
432,279
468,885
482,600
479,700
496,200
495,800
566,000
948,000
934,500
919,500
907,300
902,700
901,500
887,000
847,700
1,231,700
1,219,800
1,214,400
1,214,100
1,261,700
1,213,000
1,091,500
1,072,900
1,050,000
1,029,400
1,007,700
821,400
837,000
835,900
828,000
843,100
859,700
924,100
907,700
892,900
883,700
832,900
832,900883,700892,900907,700924,100859,700843,100828,000835,900837,000821,4001,007,7001,029,4001,050,0001,072,9001,091,5001,213,0001,261,7001,214,1001,214,4001,219,8001,231,700847,700887,000901,500902,700907,300919,500934,500948,000566,000495,800496,200479,700482,600468,885432,279432,796423,712419,236176,062173,185169,088162,715160,131159,180160,023156,924158,978159,543192,56655,83455,215118,995119,87126,408139,18983,778100,268163,856196,646165,674122,039138,009154,856140,47128,80527,42327,95325,01224,31624,27423,42022,67423,40359,80962,13362,09951,16354,80965,87367,85480,00061,68863,45067,72872,03661,74159,06755,61734,94728,77438,64031,86120,44420,23726,50033,40039,90042,70035,50045,20035,70038,10027,90023,00027,50032,80033,50025,40029,00029,20011,5000
       Property Plant Equipment 
0
6,000
7,900
9,400
10,600
11,100
11,900
12,000
12,100
12,100
12,100
12,400
12,600
9,200
10,100
10,000
10,200
9,800
10,927
11,252
11,764
12,094
12,515
12,731
12,440
12,567
12,248
15,433
17,338
18,619
18,286
18,682
18,834
18,622
17,649
17,339
16,793
16,251
15,582
18,466
17,875
18,658
19,650
19,829
20,663
23,761
23,369
24,888
25,966
28,812
28,111
30,026
28,785
29,126
28,619
22,623
22,214
24,825
24,275
23,261
23,543
22,905
21,343
23,080
23,259
24,329
24,101
24,231
24,757
27,285
26,875
27,602
30,675
31,313
32,665
34,594
43,424
46,458
69,099
67,200
64,900
61,700
60,000
58,300
56,800
54,700
53,000
51,100
49,800
48,400
48,200
43,200
60,000
59,100
58,700
57,300
126,300
103,800
101,600
103,000
99,400
100,400
104,000
129,800
127,000
125,300
116,600
135,700
178,100
187,300
203,300
218,600
224,700
180,600
180,600224,700218,600203,300187,300178,100135,700116,600125,300127,000129,800104,000100,40099,400103,000101,600103,800126,30057,30058,70059,10060,00043,20048,20048,40049,80051,10053,00054,70056,80058,30060,00061,70064,90067,20069,09946,45843,42434,59432,66531,31330,67527,60226,87527,28524,75724,23124,10124,32923,25923,08021,34322,90523,54323,26124,27524,82522,21422,62328,61929,12628,78530,02628,11128,81225,96624,88823,36923,76120,66319,82919,65018,65817,87518,46615,58216,25116,79317,33917,64918,62218,83418,68218,28618,61917,33815,43312,24812,56712,44012,73112,51512,09411,76411,25210,9279,80010,20010,00010,1009,20012,60012,40012,10012,10012,10012,00011,90011,10010,6009,4007,9006,0000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
56,051
56,850
56,850
56,850
56,850
56,850
56,850
56,850
56,850
56,850
56,850
166,746
169,181
169,181
169,181
185,228
177,200
177,300
177,000
177,900
195,300
312,800
315,400
315,000
316,100
319,000
319,400
320,200
318,600
413,300
413,200
415,900
417,200
416,100
408,100
327,100
327,600
328,300
329,200
328,300
240,100
239,700
239,200
238,800
237,800
236,500
286,800
287,100
287,200
286,600
287,400
287,400286,600287,200287,100286,800236,500237,800238,800239,200239,700240,100328,300329,200328,300327,600327,100408,100416,100417,200415,900413,200413,300318,600320,200319,400319,000316,100315,000315,400312,800195,300177,900177,000177,300177,200185,228169,181169,181169,181166,74656,85056,85056,85056,85056,85056,85056,85056,85056,85056,85056,051000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
80,064
103,106
0
70,857
69,182
95,296
147,679
132,692
136,792
129,969
147,120
180,415
180,899
158,187
65,555
84,124
54,073
42,300
41,200
40,600
43,100
66,200
69,700
79,900
52,200
55,500
53,400
48,500
50,100
58,500
51,300
30,700
24,200
29,900
40,300
54,900
51,500
47,600
42,800
37,000
30,200
21,000
11,900
19,900
47,500
59,000
70,800
78,500
66,000
54,800
30,400
6,200
0
0
006,20030,40054,80066,00078,50070,80059,00047,50019,90011,90021,00030,20037,00042,80047,60051,50054,90040,30029,90024,20030,70051,30058,50050,10048,50053,40055,50052,20079,90069,70066,20043,10040,60041,20042,30054,07384,12465,555158,187180,899180,415147,120129,969136,792132,692147,67995,29669,18270,8570103,10680,064000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,052
0
0
0
16,715
16,440
16,265
15,990
15,722
15,447
13,719
13,525
13,330
13,086
12,842
208,296
205,312
201,962
198,827
195,691
192,600
189,400
186,300
183,200
227,500
521,200
506,400
498,100
491,600
483,800
475,200
467,300
455,200
734,200
717,600
699,500
684,700
667,800
653,500
620,000
605,300
590,900
576,500
559,900
426,800
414,800
404,100
393,600
382,300
370,800
379,700
369,400
358,800
356,600
349,500
349,500356,600358,800369,400379,700370,800382,300393,600404,100414,800426,800559,900576,500590,900605,300620,000653,500667,800684,700699,500717,600734,200455,200467,300475,200483,800491,600498,100506,400521,200227,500183,200186,300189,400192,600195,691198,827201,962205,312208,29612,84213,08613,33013,52513,71915,44715,72215,99016,26516,44016,7150002,05200000000000000000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,310
9,192
20,097
26,546
16,259
22,216
43,177
46,500
49,493
56,603
50,390
44,831
43,402
61,318
49,020
47,251
37,160
33,824
45,306
45,882
44,227
4,937
4,799
4,762
4,624
4,487
4,349
4,192
4,054
3,917
114,505
126,044
109,898
92,013
136,889
167,520
135,237
77,645
61,564
114,364
114,667
96,610
95,452
125,892
120,331
169,486
177,997
204,492
256,483
243,912
243,170
233,128
254,448
292,227
292,308
270,862
445,597
466,797
430,216
415,308
427,526
415,400
414,800
434,500
435,800
507,700
891,200
879,800
866,500
856,200
852,900
853,100
838,800
804,500
1,171,700
0
0
0
0
0
0
0
1,200
2,300
3,600
4,800
8,000
8,300
8,200
8,800
8,300
8,400
17,500
22,100
0
0
0022,10017,5008,4008,3008,8008,2008,3008,0004,8003,6002,3001,20000000001,171,700804,500838,800853,100852,900856,200866,500879,800891,200507,700435,800434,500414,800415,400427,526415,308430,216466,797445,597270,862292,308292,227254,448233,128243,170243,912256,483204,492177,997169,486120,331125,89295,45296,610114,667114,36461,56477,645135,237167,520136,88992,013109,898126,044114,5053,9174,0544,1924,3494,4874,6244,7624,7994,93744,22745,88245,30633,82437,16047,25149,02061,31843,40244,83150,39056,60349,49346,50043,17722,21616,25926,54620,0979,1929,310000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,416
20,795
0
25,863
27,525
28,081
27,964
30,648
26,081
24,590
28,953
28,632
28,473
29,983
0
3,180
0
0
407
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000407003,180029,98328,47328,63228,95324,59026,08130,64827,96428,08127,52525,863020,79513,416000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
5,300
9,300
9,400
10,000
9,600
8,700
9,900
10,000
9,800
9,200
9,900
7,800
6,600
5,800
5,400
14,300
18,400
22,617
28,669
24,029
21,703
23,014
32,584
21,971
20,357
18,932
28,521
16,085
21,669
12,919
19,337
12,210
12,890
14,840
15,080
13,861
17,359
16,539
23,285
22,347
23,583
21,593
26,822
22,947
26,472
22,960
31,704
31,622
34,890
37,661
73,687
54,184
53,821
36,503
32,202
20,993
22,711
22,217
36,266
39,731
32,508
32,820
44,035
40,741
44,494
47,060
54,975
67,494
55,626
64,099
75,227
91,386
80,710
94,184
104,816
96,856
87,613
110,151
104,100
99,900
100,900
98,000
132,400
535,600
543,400
519,900
446,600
357,700
314,300
270,100
209,200
471,400
492,500
475,600
473,800
516,700
501,000
479,500
486,400
535,200
538,900
461,700
457,900
367,400
352,900
305,300
262,800
295,400
312,900
334,100
452,000
465,700
363,300
363,300465,700452,000334,100312,900295,400262,800305,300352,900367,400457,900461,700538,900535,200486,400479,500501,000516,700473,800475,600492,500471,400209,200270,100314,300357,700446,600519,900543,400535,600132,40098,000100,90099,900104,100110,15187,61396,856104,81694,18480,71091,38675,22764,09955,62667,49454,97547,06044,49440,74144,03532,82032,50839,73136,26622,21722,71120,99332,20236,50353,82154,18473,68737,66134,89031,62231,70422,96026,47222,94726,82221,59323,58322,34723,28516,53917,35913,86115,08014,84012,89012,21019,33712,91921,66916,08528,52118,93220,35721,97132,58423,01421,70324,02928,66922,61718,40014,3005,4005,8006,6007,8009,9009,2009,80010,0009,9008,7009,60010,0009,4009,3005,3000
   > Total Current Liabilities 
0
4,700
8,800
9,000
9,700
9,300
8,500
9,800
9,900
9,900
9,300
9,900
7,800
6,600
5,900
5,300
14,400
18,400
22,618
28,669
24,029
21,703
23,014
32,584
21,971
20,357
18,932
28,521
16,085
21,669
12,919
19,337
12,210
12,890
14,840
15,080
13,861
17,359
16,539
23,285
22,347
23,583
21,593
26,822
22,947
26,472
22,960
31,704
31,622
34,890
37,661
73,687
54,184
53,821
36,503
32,202
20,993
22,711
22,217
27,466
30,931
32,508
32,820
34,387
40,741
44,494
47,060
44,967
57,356
45,488
53,621
64,509
79,030
67,392
72,156
80,578
67,725
59,837
67,173
68,700
59,000
65,900
66,100
72,300
274,900
82,800
221,700
217,500
139,200
159,300
94,300
102,200
108,000
113,300
108,900
117,800
115,400
112,400
113,200
147,000
133,700
145,900
149,000
271,000
203,200
204,300
166,000
119,700
129,100
137,200
143,300
221,100
209,300
155,900
155,900209,300221,100143,300137,200129,100119,700166,000204,300203,200271,000149,000145,900133,700147,000113,200112,400115,400117,800108,900113,300108,000102,20094,300159,300139,200217,500221,70082,800274,90072,30066,10065,90059,00068,70067,17359,83767,72580,57872,15667,39279,03064,50953,62145,48857,35644,96747,06044,49440,74134,38732,82032,50830,93127,46622,21722,71120,99332,20236,50353,82154,18473,68737,66134,89031,62231,70422,96026,47222,94726,82221,59323,58322,34723,28516,53917,35913,86115,08014,84012,89012,21019,33712,91921,66916,08528,52118,93220,35721,97132,58423,01421,70324,02928,66922,61818,40014,4005,3005,9006,6007,8009,9009,3009,9009,9009,8008,5009,3009,7009,0008,8004,7000
       Short-term Debt 
0
300
300
300
300
300
300
300
400
300
200
100
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,591
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,448
9,448
10,008
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
199,200
0
64,000
65,600
59,800
60,800
64,100
68,300
76,400
73,700
78,800
78,900
13,000
12,800
12,900
13,500
13,600
13,600
14,000
116,800
12,800
13,000
13,400
13,300
14,000
14,100
15,100
17,000
17,800
0
017,80017,00015,10014,10014,00013,30013,40013,00012,800116,80014,00013,60013,60013,50012,90012,80013,00078,90078,80073,70076,40068,30064,10060,80059,80065,60064,0000199,2000000000000000000010,0089,4489,4480000000000000000000000000000000000003,591000000000000001001002003004003003003003003003003000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
199,200
0
0
99,100
74,200
43,200
69,300
9,300
0
0
0
0
0
0
0
0
0
0
0
104,100
0
0
0
0
0
0
0
0
0
0
0000000000104,100000000000009,30069,30043,20074,20099,10000199,200000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
1,900
2,900
2,200
2,500
2,300
1,700
2,600
1,700
3,000
3,200
5,100
3,800
3,200
4,100
2,900
2,000
3,400
3,870
4,262
3,969
4,595
5,422
9,657
5,703
6,743
5,307
9,462
5,862
11,609
4,653
11,454
5,809
3,890
8,927
7,938
6,601
8,309
7,899
11,897
9,720
14,708
10,492
11,804
11,650
15,197
10,998
15,763
13,993
13,910
12,009
24,884
14,999
12,771
11,426
14,177
7,648
9,403
7,026
8,870
7,242
7,050
5,191
11,395
9,827
8,876
7,939
10,141
11,086
13,575
12,238
18,132
18,745
17,596
18,935
23,078
25,728
16,833
17,955
21,100
15,800
16,500
13,800
21,100
19,900
22,900
26,800
22,000
22,500
25,100
20,200
26,000
23,800
31,900
24,100
33,300
24,000
21,000
30,300
21,700
19,100
20,500
20,800
28,500
15,700
29,600
27,100
21,700
29,600
28,800
36,500
39,800
33,900
25,800
25,80033,90039,80036,50028,80029,60021,70027,10029,60015,70028,50020,80020,50019,10021,70030,30021,00024,00033,30024,10031,90023,80026,00020,20025,10022,50022,00026,80022,90019,90021,10013,80016,50015,80021,10017,95516,83325,72823,07818,93517,59618,74518,13212,23813,57511,08610,1417,9398,8769,82711,3955,1917,0507,2428,8707,0269,4037,64814,17711,42612,77114,99924,88412,00913,91013,99315,76310,99815,19711,65011,80410,49214,7089,72011,8977,8998,3096,6017,9388,9273,8905,80911,4544,65311,6095,8629,4625,3076,7435,7039,6575,4224,5953,9694,2623,8703,4002,0002,9004,1003,2003,8005,1003,2003,0001,7002,6001,7002,3002,5002,2002,9001,9000
       Other Current Liabilities 
0
2,500
5,600
6,500
6,900
6,700
6,500
6,900
7,800
6,600
5,900
4,700
4,000
3,400
1,800
2,400
12,400
15,000
18,748
24,406
20,060
17,109
2,937
3,083
3,400
3,863
3,080
1,037
3,250
4,137
4,342
4,925
4,026
6,779
4,224
5,933
6,103
7,432
7,305
10,136
8,628
7,583
9,999
14,901
11,239
10,841
11,555
15,558
17,620
20,647
23,594
46,770
39,177
40,820
25,019
17,992
13,345
13,308
15,191
18,596
23,689
25,458
27,629
21,645
20,383
23,736
27,726
32,772
42,995
29,192
38,352
44,334
59,390
45,844
51,103
56,410
40,654
41,180
47,879
46,100
41,800
47,900
50,800
49,500
54,800
57,700
128,200
127,300
54,000
70,000
7,400
5,300
5,300
5,300
3,700
3,400
76,300
75,000
66,200
79,000
68,700
79,100
83,100
103,100
163,200
156,500
124,800
84,400
85,300
93,700
91,700
164,300
157,600
10,400
10,400157,600164,30091,70093,70085,30084,400124,800156,500163,200103,10083,10079,10068,70079,00066,20075,00076,3003,4003,7005,3005,3005,3007,40070,00054,000127,300128,20057,70054,80049,50050,80047,90041,80046,10047,87941,18040,65456,41051,10345,84459,39044,33438,35229,19242,99532,77227,72623,73620,38321,64527,62925,45823,68918,59615,19113,30813,34517,99225,01940,82039,17746,77023,59420,64717,62015,55811,55510,84111,23914,9019,9997,5838,62810,1367,3057,4326,1035,9334,2246,7794,0264,9254,3424,1373,2501,0373,0803,8633,4003,0832,93717,10920,06024,40618,74815,00012,4002,4001,8003,4004,0004,7005,9006,6007,8006,9006,5006,7006,9006,5005,6002,5000
   > Long-term Liabilities 
0
600
500
400
300
300
200
100
100
-100
-100
5,200
3,800
3,200
-100
100
-100
3,400
-1
4,262
3,969
4,595
20,076
29,501
18,572
16,494
15,852
23,892
12,835
17,532
8,577
14,412
8,184
6,111
10,616
9,147
7,758
9,927
9,234
13,149
13,719
16,000
11,594
11,921
11,708
15,631
11,405
16,146
14,002
14,243
14,067
26,917
15,007
13,001
11,484
14,210
7,648
9,403
7,026
8,800
8,800
9,320
9,448
9,648
9,448
9,448
10,008
10,008
10,138
10,138
10,478
10,718
12,356
13,318
22,028
24,238
29,131
27,776
42,978
35,400
40,900
35,000
31,900
60,100
260,700
460,600
298,200
229,100
218,500
155,000
175,800
107,000
363,400
379,200
366,700
356,000
401,300
388,600
366,300
339,400
401,500
393,000
312,700
186,900
164,200
148,600
139,300
143,100
166,300
175,700
190,800
230,900
256,400
207,400
207,400256,400230,900190,800175,700166,300143,100139,300148,600164,200186,900312,700393,000401,500339,400366,300388,600401,300356,000366,700379,200363,400107,000175,800155,000218,500229,100298,200460,600260,70060,10031,90035,00040,90035,40042,97827,77629,13124,23822,02813,31812,35610,71810,47810,13810,13810,00810,0089,4489,4489,6489,4489,3208,8008,8007,0269,4037,64814,21011,48413,00115,00726,91714,06714,24314,00216,14611,40515,63111,70811,92111,59416,00013,71913,1499,2349,9277,7589,14710,6166,1118,18414,4128,57717,53212,83523,89215,85216,49418,57229,50120,0764,5953,9694,262-13,400-100100-1003,2003,8005,200-100-1001001002003003004005006000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
204,000
167,100
99,100
74,200
43,200
69,300
9,300
258,000
273,300
263,400
233,500
225,000
225,100
225,200
224,400
224,600
0
154,000
0
0
0
0
0
0
0
0
0
0
0
00000000000154,0000224,600224,400225,200225,100225,000233,500263,400273,300258,0009,30069,30043,20074,20099,100167,100204,0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,416
20,795
0
25,863
27,525
28,081
27,964
30,648
26,081
24,590
28,953
28,632
28,473
29,983
0
3,180
0
0
407
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000407003,180029,98328,47328,63228,95324,59026,08130,64827,96428,08127,52525,863020,79513,416000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,800
8,800
9,320
9,448
9,648
9,448
9,448
10,008
10,008
10,138
10,138
10,478
10,718
12,356
13,318
13,641
24,238
24,514
25,326
42,978
35,200
34,300
34,700
31,700
42,200
173,100
170,500
46,400
45,600
53,100
51,000
106,500
97,700
105,400
105,900
103,300
122,500
113,700
104,800
85,200
58,100
123,400
117,600
109,300
103,000
83,500
69,300
62,800
55,700
43,000
44,800
44,300
44,100
0
0
0044,10044,30044,80043,00055,70062,80069,30083,500103,000109,300117,600123,40058,10085,200104,800113,700122,500103,300105,900105,40097,700106,50051,00053,10045,60046,400170,500173,10042,20031,70034,70034,30035,20042,97825,32624,51424,23813,64113,31812,35610,71810,47810,13810,13810,00810,0089,4489,4489,6489,4489,3208,8008,80000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,387
0
4,617
2,450
10,447
200
6,600
300
200
17,900
87,600
86,100
84,700
84,400
91,200
60,800
62,200
57,300
64,900
64,000
65,800
82,600
76,900
75,500
59,300
26,600
75,300
0
59,200
0
0
0
0
0
0
0
0
0
0
0
0000000000059,200075,30026,60059,30075,50076,90082,60065,80064,00064,90057,30062,20060,80091,20084,40084,70086,10087,60017,9002003006,60020010,4472,4504,61708,38700000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
73,400
71,800
70,200
67,600
64,300
61,500
66,200
64,600
62,800
60,300
57,500
55,000
52,500
50,400
48,200
50,800
55,500
55,251
77,707
98,199
139,778
139,231
139,562
139,272
138,567
134,738
128,870
124,017
175,441
169,998
163,486
153,766
144,105
133,489
173,276
163,617
154,003
144,041
135,673
127,688
261,646
256,700
249,781
239,869
235,850
339,189
340,363
341,748
349,468
353,296
425,655
477,044
519,746
583,927
434,219
473,136
517,326
567,346
557,581
571,111
561,101
524,460
566,792
578,994
616,764
652,193
635,660
635,567
662,120
664,929
728,594
690,272
675,971
722,242
718,998
712,150
694,241
668,898
662,100
687,100
770,800
770,200
748,100
735,500
732,900
748,200
778,200
870,900
914,200
948,300
964,900
1,102,200
1,064,200
1,081,800
1,088,900
1,074,500
1,077,200
967,200
918,200
909,300
879,900
875,200
902,500
968,600
967,800
950,100
947,400
916,600
885,800
835,200
735,200
683,400
783,200
783,200683,400735,200835,200885,800916,600947,400950,100967,800968,600902,500875,200879,900909,300918,200967,2001,077,2001,074,5001,088,9001,081,8001,064,2001,102,200964,900948,300914,200870,900778,200748,200732,900735,500748,100770,200770,800687,100662,100668,898694,241712,150718,998722,242675,971690,272728,594664,929662,120635,567635,660652,193616,764578,994566,792524,460561,101571,111557,581567,346517,326473,136434,219583,927519,746477,044425,655353,296349,468341,748340,363339,189235,850239,869249,781256,700261,646127,688135,673144,041154,003163,617173,276133,489144,105153,766163,486169,998175,441124,017128,870134,738138,567139,272139,562139,231139,77898,19977,70755,25155,50050,80048,20050,40052,50055,00057,50060,30062,80064,60066,20061,50064,30067,60070,20071,80073,4000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
100
104
219
223
231
233
234
235
237
238
238
238
270
270
271
271
271
272
306
307
307
308
309
309
391
394
397
397
399
430
434
439
444
446
447
464
467
954
959
962
964
976
940
924
901
857
862
846
842
845
826
814
813
797
806
768
740
745
735
729
719
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
800
800
800
800
800
800
800
800
800
800
800
800
800
0
0800800800800800800800800800800800800800700700700700700700700700700700700700700700700700700700700700700700719729735745740768806797813814826845842846862857901924940976964962959954467464447446444439434430399397397394391309309308307307306272271271271270270238238238237235234233231223219104100100100000000000000000
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-3,758
-20,661
-48,082
-38,630
-38,299
-21,430
-88
-12,684
-14,997
-4,272
2,050
30,866
13,955
11,603
18,865
2,004
-17,449
-36,975
-62,282
-77,000
-78,800
-68,600
-69,200
-73,200
-86,500
-85,700
-81,400
-68,400
12,800
44,800
56,200
52,900
53,400
22,900
29,800
25,600
5,000
-3,300
-118,500
-173,900
-189,100
0
-266,500
0
0
0
0
0
0
0
0
0
0
0
00000000000-266,5000-189,100-173,900-118,500-3,3005,00025,60029,80022,90053,40052,90056,20044,80012,800-68,400-81,400-85,700-86,500-73,200-69,200-68,600-78,800-77,000-62,282-36,975-17,4492,00418,86511,60313,95530,8662,050-4,272-14,997-12,684-88-21,430-38,299-38,630-48,082-20,661-3,758000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
-800
-1,000
-1,400
-1,700
-2,200
-2,700
-3,200
-3,800
-4,500
-5,200
-5,900
-6,700
-5,800
-6,400
-300
-300
-200
-119
-85
-62
65
263
364
818
346
-160
308
560
631
707
711
560
311
265
-212
-111
-403
-784
-534
-640
-672
-738
-746
-401
-281
-133
-398
63
516
1,264
-237
-6,613
446
656
2,768
2,672
1,854
1,155
139
262
99
100
151
-113
-253
-99
-162
129
-221
-459
-424
365
506
-122
-1,515
-2,368
-4,182
-7,560
-7,000
-7,100
-9,100
-8,300
-9,500
-5,600
-13,900
-10,600
-5,500
-2,200
-2,400
1,800
-4,000
-4,300
-5,000
-5,700
-5,400
-7,500
-5,300
-7,800
-5,200
-3,600
2,900
-3,600
-4,000
-4,400
-5,100
-7,600
-8,900
-11,300
-8,900
-7,400
-5,400
-5,300
0
0-5,300-5,400-7,400-8,900-11,300-8,900-7,600-5,100-4,400-4,000-3,6002,900-3,600-5,200-7,800-5,300-7,500-5,400-5,700-5,000-4,300-4,0001,800-2,400-2,200-5,500-10,600-13,900-5,600-9,500-8,300-9,100-7,100-7,000-7,560-4,182-2,368-1,515-122506365-424-459-221129-162-99-253-113151100992621391,1551,8542,6722,768656446-6,613-2371,26451663-398-133-281-401-746-738-672-640-534-784-403-111-212265311560711707631560308-16034681836426365-62-85-119-200-300-300-6,400-5,800-6,700-5,900-5,200-4,500-3,800-3,200-2,700-2,200-1,700-1,400-1,000-8000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
573,683
580,762
571,585
604,409
616,560
637,605
651,535
647,680
649,621
665,800
662,541
697,346
675,184
663,122
702,754
717,774
731,238
734,679
738,040
745,400
772,300
847,800
847,000
830,100
826,900
831,800
839,500
851,400
859,600
871,100
889,600
915,400
1,052,400
1,045,600
1,057,000
1,068,000
1,076,300
1,085,100
1,092,800
1,096,600
1,101,200
0
1,144,500
0
0
0
0
0
0
0
0
0
0
0
000000000001,144,50001,101,2001,096,6001,092,8001,085,1001,076,3001,068,0001,057,0001,045,6001,052,400915,400889,600871,100859,600851,400839,500831,800826,900830,100847,000847,800772,300745,400738,040734,679731,238717,774702,754663,122675,184697,346662,541665,800649,621647,680651,535637,605616,560604,409571,585580,762573,683000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
84,700
84,800
85,100
85,400
85,500
86,000
90,300
90,500
91,000
91,200
91,400
91,600
92,000
92,100
92,300
97,100
103,600
105,364
130,235
152,770
195,405
196,385
198,800
199,240
201,465
201,638
202,149
202,361
260,577
260,591
261,155
261,195
261,637
261,762
312,453
312,684
313,410
313,814
315,147
316,510
458,370
463,058
467,568
469,736
474,391
583,488
592,727
601,645
613,973
621,682
630,000
673,294
687,731
725,897
550,432
559,000
568,646
586,102
566,967
573,683
580,762
571,585
604,409
616,560
637,605
651,535
647,680
649,621
665,800
662,541
697,346
675,184
663,122
702,754
717,774
731,238
734,679
738,040
745,400
772,300
847,800
847,000
830,100
826,900
831,800
839,500
851,400
859,600
871,100
889,600
915,400
1,052,400
1,045,600
1,057,000
1,068,000
1,076,300
1,085,100
1,092,800
1,096,600
1,101,200
1,109,500
1,144,500
1,176,900
1,218,800
1,226,300
1,231,600
1,244,300
1,251,000
1,260,100
1,262,700
1,276,800
1,286,200
0
01,286,2001,276,8001,262,7001,260,1001,251,0001,244,3001,231,6001,226,3001,218,8001,176,9001,144,5001,109,5001,101,2001,096,6001,092,8001,085,1001,076,3001,068,0001,057,0001,045,6001,052,400915,400889,600871,100859,600851,400839,500831,800826,900830,100847,000847,800772,300745,400738,040734,679731,238717,774702,754663,122675,184697,346662,541665,800649,621647,680651,535637,605616,560604,409571,585580,762573,683566,967586,102568,646559,000550,432725,897687,731673,294630,000621,682613,973601,645592,727583,488474,391469,736467,568463,058458,370316,510315,147313,814313,410312,684312,453261,762261,637261,195261,155260,591260,577202,361202,149201,638201,465199,240198,800196,385195,405152,770130,235105,364103,60097,10092,30092,10092,00091,60091,40091,20091,00090,50090,30086,00085,50085,40085,10084,80084,7000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue678,400
Cost of Revenue-202,000
Gross Profit476,400476,400
 
Operating Income (+$)
Gross Profit476,400
Operating Expense-600,100
Operating Income-123,700-123,700
 
Operating Expense (+$)
Research Development85,400
Selling General Administrative514,700
Selling And Marketing Expenses0
Operating Expense600,100600,100
 
Net Interest Income (+$)
Interest Income2,600
Interest Expense-3,200
Other Finance Cost-0
Net Interest Income-600
 
Pretax Income (+$)
Operating Income-123,700
Net Interest Income-600
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-140,600-106,800
EBIT - interestExpense = -126,900
-140,600
-108,800
Interest Expense3,200
Earnings Before Interest and Taxes (EBIT)-123,700-137,400
Earnings Before Interest and Taxes (EBITDA)-67,800
 
After tax Income (+$)
Income Before Tax-140,600
Tax Provision--28,600
Net Income From Continuing Ops-112,000-112,000
Net Income-112,000
Net Income Applicable To Common Shares-112,000
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses802,100
Total Other Income/Expenses Net-16,900600
 

Technical Analysis of Myriad
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Myriad. The general trend of Myriad is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Myriad's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Myriad Genetics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 19.57 < 20.58 < 20.59.

The bearish price targets are: 17.18 > 16.00 > 13.82.

Tweet this
Myriad Genetics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Myriad Genetics Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Myriad Genetics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Myriad Genetics Inc. The current macd is -0.82725042.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Myriad price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Myriad. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Myriad price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Myriad Genetics Inc Daily Moving Average Convergence/Divergence (MACD) ChartMyriad Genetics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Myriad Genetics Inc. The current adx is 29.64.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Myriad shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Myriad Genetics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Myriad Genetics Inc. The current sar is 20.13.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Myriad Genetics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Myriad Genetics Inc. The current rsi is 30.91. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Myriad Genetics Inc Daily Relative Strength Index (RSI) ChartMyriad Genetics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Myriad Genetics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Myriad price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Myriad Genetics Inc Daily Stochastic Oscillator ChartMyriad Genetics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Myriad Genetics Inc. The current cci is -97.49770578.

Myriad Genetics Inc Daily Commodity Channel Index (CCI) ChartMyriad Genetics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Myriad Genetics Inc. The current cmo is -47.36227894.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Myriad Genetics Inc Daily Chande Momentum Oscillator (CMO) ChartMyriad Genetics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Myriad Genetics Inc. The current willr is -86.31578947.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Myriad Genetics Inc Daily Williams %R ChartMyriad Genetics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Myriad Genetics Inc.

Myriad Genetics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Myriad Genetics Inc. The current atr is 0.76307004.

Myriad Genetics Inc Daily Average True Range (ATR) ChartMyriad Genetics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Myriad Genetics Inc. The current obv is -6,530,014.

Myriad Genetics Inc Daily On-Balance Volume (OBV) ChartMyriad Genetics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Myriad Genetics Inc. The current mfi is 41.76.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Myriad Genetics Inc Daily Money Flow Index (MFI) ChartMyriad Genetics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Myriad Genetics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside

6.3. Candlestick Patterns

Myriad Genetics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Myriad Genetics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.907
Ma 20Greater thanMa 5019.940
Ma 50Greater thanMa 10021.390
Ma 100Greater thanMa 20020.781
OpenGreater thanClose18.510
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Myriad with someone you think should read this too:
  • Are you bullish or bearish on Myriad? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Myriad? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Myriad Genetics Inc

I send you an email if I find something interesting about Myriad Genetics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Myriad Genetics Inc.

Receive notifications about Myriad Genetics Inc in your mailbox!